These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15035068)

  • 1. [Guideline for the treatment of leprosy by new quinolones].
    Gidoh M; Namisato M; Kumano K; Goto M; Nogami R; Ozaki M;
    Nihon Hansenbyo Gakkai Zasshi; 2004 Feb; 73(1):65-7. PubMed ID: 15035068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term follow-up of ofloxacin-combined therapy for leprosy patients].
    Ozaki M; Ishikawa M
    Nihon Hansenbyo Gakkai Zasshi; 2007 Sep; 76(3):207-18. PubMed ID: 17877033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of Hansen's disease in Japan--present status].
    Goto M; Miyagi S; Takizawa H; Kitajima S
    Nihon Hansenbyo Gakkai Zasshi; 1998 Jul; 67(2):305-11. PubMed ID: 9785846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin-containing combined drug regimens in the treatment of lepromatous leprosy.
    Rao PS; Ramachandran A; Sekar B; Ravi S; Subramanian M
    Lepr Rev; 1994 Sep; 65(3):181-9. PubMed ID: 8942149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions.
    Ramu G
    Lepr Rev; 1998 Mar; 69(1):78-82. PubMed ID: 9628098
    [No Abstract]   [Full Text] [Related]  

  • 8. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract]   [Full Text] [Related]  

  • 10. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
    Lockwood DN; Cunha Mda G
    Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
    [No Abstract]   [Full Text] [Related]  

  • 12. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-dose treatment for single lesion leprosy; histopathological observations.
    Shinde A; Khopkar U; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099
    [No Abstract]   [Full Text] [Related]  

  • 14. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 15. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 16. Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy.
    Gupte MD
    Lepr Rev; 2000 Dec; 71 Suppl():S77-80. PubMed ID: 11201893
    [No Abstract]   [Full Text] [Related]  

  • 17. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guideline for the treatment of Hansen's disease in Japan].
    Goto M; Ishida Y; Gidoh M; Nagao E; Namisato M; Ishii N; Ozaki M;
    Nihon Hansenbyo Gakkai Zasshi; 2000 Nov; 69(3):157-77. PubMed ID: 11187723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of alternative therapy (minocycline, ofloxacin, and clofazimine) in multibacillary leprosy patients in a recognized health care unit in Manaus, Amazonas, Brazil.
    Maia MV; Cunha Mda G; Cunha CS
    An Bras Dermatol; 2013; 88(2):205-10. PubMed ID: 23739719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
    Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.